Contact us contattaci
logo
logo
Home / Magazine / R&D Innovation / UTIs: Nutraceutical Business Review interviews Dr. De Seta, a specialist in obstetrics and gynecology
Back to the archive

UTIs: Nutraceutical Business Review interviews Dr. De Seta, a specialist in obstetrics and gynecology

Data: 28_07_2022
Category: R&D Innovation

What are UTIs and how can they be treated?

In this Nutraceutical Business Review interview, Francesco De Seta, Professor of Gynaecology and Obstetrics at the University of Trieste and Medical Director at the IRCCS Materno Infantile Burlo Garofolo, explains the main features of urinary tract infections. An analysis of the characteristics and data relating to this increasingly common pathology and an innovative nutraceutical formula capable of counteracting it: DAPAD, a dietary supplement with a clinical trial to support patients suffering from urinary tract infections, developed by Biofarma Group.

Want to learn more? Contact us

Captcha non valido!

loading
Contacts image
logo
© Biofarma Srl C.F. and P.IVA 02895910301
T. +39 0432 868711 F. +39 0432 868018
Via Castelliere, 2
33036 Mereto di Tomba (UD) Italy
Number REA UD - 296214
Date of entry in the
Business Register of UDINE: 01/07/2017
Registration number: 02895910301
Share capital euro 3.000.000